What Are Semaglutide and Tirzepatide?

Semaglutide and tirzepatide are prescription medications that can help eligible patients manage their weight when combined with reduced-calorie eating and increased physical activity. Semaglutide acts on GLP-1 receptors involved in appetite and blood sugar regulation. Tirzepatide acts on both GIP and GLP-1 receptors. At Age Management of West Michigan, a medical evaluation can help determine whether either medication may be appropriate for your weight-management goals.

What Is the Difference Between Semaglutide and Tirzepatide?

The main difference is how the medications work. Semaglutide targets the GLP-1 receptor, while tirzepatide targets both GIP and GLP-1 receptors. Both can reduce appetite and support weight loss, but clinical trial results, side effects, dosing, and individual responses differ. Neither medication is automatically the best choice for everyone; a physician can help evaluate the potential benefits and risks based on your health history and treatment goals.

Which Is More Effective for Weight Loss, Semaglutide or Tirzepatide?

Both medications have demonstrated significant weight-loss effects in clinical studies. In a 2025 head-to-head trial involving adults with obesity or overweight and at least one weight-related condition, tirzepatide produced greater average weight loss than semaglutide over 72 weeks. Individual results vary, and the study findings do not guarantee a particular outcome for any patient. Your physician can discuss how the evidence applies to your circumstances.

How Do Semaglutide and Tirzepatide Help With Weight Loss?

These medications affect hormone signaling involved in appetite, fullness, and food intake. The main mechanism for supporting weight loss is blocking certain hormones that have an effect on Insulin release after food consumption. They can help patients feel satisfied sooner and reduce hunger, making it easier to follow a reduced-calorie eating plan. Treatment works best as part of a comprehensive weight-management approach that includes nutrition, physical activity, and appropriate medical follow-up.

Are Semaglutide and Tirzepatide Weight Loss Injections?

Injectable semaglutide and tirzepatide are administered under the skin according to the prescribed schedule. Age Management of West Michigan offers compounded forms of both semaglutide and tirzepatide injections for weight loss.

What Are the Side Effects of Semaglutide and Tirzepatide?

Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal discomfort. Symptoms may be more noticeable when starting treatment or increasing the dose. More serious complications can occur, including pancreatitis, gallbladder problems, or dehydration-related kidney problems. Seek prompt medical attention for severe or persistent abdominal pain, persistent vomiting, or other concerning symptoms. Your AMWM physician will review your medical history and discuss potential risks before treatment.

Are Semaglutide and Tirzepatide Safe for Weight Loss?

Semaglutide and tirzepatide can be appropriate for eligible patients when prescribed for an approved indication and used with appropriate medical supervision. However, neither medication is suitable for everyone. Both have important warnings and precautions, including a contraindication for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). A physician should review your health history, medications, and individual risk factors before treatment.

Who Qualifies for Semaglutide or Tirzepatide for Weight Loss?

Eligibility is determined by AMWM physician clearance and depends on the specific medication, medical indication, body mass index (BMI), weight-related health conditions, medical history, and potential contraindications.   Age Management requires a BMI > 25 to be eligible to start semaglutide or tirzepatide weight loss injections.

What Happens When You Stop Taking Semaglutide or Tirzepatide?

Some people regain weight after stopping treatment because appetite and hunger may increase again. Obesity is often a chronic condition, and long-term weight management may require continued medical care, nutrition strategies, physical activity, and follow-up. Before stopping a medication, discuss a maintenance plan with your physician.

How Much Do Semaglutide and Tirzepatide Weight Loss Programs Cost in Grand Rapids, MI?

Semaglutide or tirzepatide injections are included as part of the GLP-1 Medical Weight Loss program offered at Age Management of West Michgian, but are also available to be purchased in individual doses for on-going long term treatment. Age Management of West Michigan has a variety of treatment options available with GLP-1 injections starting as low as $299 per month.   Semaglutide and Tirzepatide injections are HSA and FSA insurance approved at AMWM.

Where Can I Get Physician-Supervised Semaglutide or Tirzepatide for Weight Loss in Grand Rapids, MI?

Age Management of West Michigan offers physician-guided GLP-1 medical weight-management services in Grand Rapids, Michigan, and for patients throughout Michigan.  Semaglutide and tirzepatide injections are available along with other weight loss injection options.  An individualized evaluation can help determine whether semaglutide, tirzepatide, or another weight-management approach may be suitable based on your medical history, health needs, and goals. Contact AMWM to schedule your FREE weight loss consultation to discuss available options.